Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-09 09:02 am Purchase | 2024-09-30 | 13G | Empery Digital Inc. EMPD | Empery Asset Management, LP | 52,162 0.980% | 52,162 (New Position) | Filing History |
| 2024-10-09 09:01 am Unchanged | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | Empery Asset Management, LP | 4,000,000 4.990% | 0 (Unchanged) | Filing History |
| 2024-10-09 09:01 am Purchase | 2024-09-30 | 13G | Sharps Technology, Inc. STSS | Empery Asset Management, LP | 539 4.990% | 539 (New Position) | Filing History |
| 2024-10-09 09:00 am Purchase | 2024-09-30 | 13G | SOBR Safe, Inc. SOBR | Empery Asset Management, LP | 57,093 1.620% | 57,093 (New Position) | Filing History |
| 2024-01-23 12:51 pm Unchanged | 2023-12-31 | 13G | Cyngn Inc. CYN | Empery Asset Management, LP | 373 4.990% | 0 (Unchanged) | Filing History |
| 2024-01-11 4:53 pm Purchase | 2023-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP | Empery Asset Management, LP | 17,399 9.990% | 17,399 (New Position) | Filing History |
| 2024-01-11 3:55 pm Purchase | 2023-12-31 | 13G | Empery Digital Inc. EMPD | Empery Asset Management, LP | 21,080,129 9.990% | 21,080,129 (New Position) | Filing History |
| 2024-01-10 09:00 am Purchase | 2023-12-31 | 13G | Cyngn Inc. CYN | Empery Asset Management, LP | 373 9.990% | 373 (New Position) | Filing History |
| 2024-01-09 09:07 am Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | Empery Asset Management, LP | 4,000,000 6.700% | 4,000,000 (New Position) | Filing History |
| 2024-01-09 09:06 am Purchase | 2023-12-31 | 13G | Cyngn Inc. CYN | Empery Asset Management, LP | 354 9.990% | 354 (New Position) | Filing History |
| 2024-01-09 09:05 am Purchase | 2023-12-31 | 13G | SOBR Safe, Inc. SOBR | Empery Asset Management, LP | 1,092 6.090% | 1,092 (New Position) | Filing History |
| 2024-01-09 09:03 am Purchase | 2023-12-31 | 13G | Nuvve Holding Corp. NVVE | Empery Asset Management, LP | 11,260 9.990% | 11,260 (New Position) | Filing History |
| 2024-01-08 10:26 am Sale | 2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Empery Asset Management, LP | 151,654 2.650% | -54,969 (-26.60%) | Filing History |
| 2024-01-08 10:25 am Unchanged | 2023-12-31 | 13G | Kiromic BioPharma, Inc. KRBP | Empery Asset Management, LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-01-08 10:23 am Purchase | 2023-12-31 | 13G | RedHill Biopharma Ltd. RDHL | Empery Asset Management, LP | 414,607 3.190% | 414,607 (New Position) | Filing History |
| 2024-01-08 10:22 am Purchase | 2023-12-31 | 13G | Permex Petroleum Corporation OILCF | Empery Asset Management, LP | 52,083 4.990% | 52,083 (New Position) | Filing History |
| 2023-01-13 08:04 am Purchase | 2022-12-31 | 13G | RedHill Biopharma Ltd. RDHL | Empery Asset Management, LP | 6,200 6.120% | 6,200 (New Position) | Filing History |
| 2023-01-13 08:02 am Purchase | 2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Empery Asset Management, LP | 206,623 5.120% | 206,623 (New Position) | Filing History |
| 2023-01-13 08:00 am Purchase | 2022-12-31 | 13G | Empery Digital Inc. EMPD | Empery Asset Management, LP | 12,077,295 9.990% | 12,077,295 (New Position) | Filing History |
| 2023-01-12 10:03 am Purchase | 2022-12-31 | 13G | Permex Petroleum Corporation OILCF | Empery Asset Management, LP | 13,021 9.580% | 13,021 (New Position) | Filing History |